We are helping address COVID-19 by providing PPE to our community. Please visit our pop-up store online to see what is currently available and place orders. Additionally, support is still available for “normal business” needs, clinical support and education for Restech’s pH system and Stretta.
October 6, 2018

Stretta Therapy Improves Quality of Life & Reduces PPI Dependency

January 19, 2018

Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease.

May 30, 2017

Stretta Presentations and New Data at DDW 2017 Highlight Positive Outcomes

Mederi Therapeutics announced highlights of educational activities on Stretta Therapy for Gastroesophageal Reflux Disease (GERD) that took place at Digestive Disease Week® 2017 (DDW 2017). The activities included a presentation on "Unmet Needs in GERD Treatment", presented by Dr. Ronnie Fass and Professor Jan Tack. The presentation featured data from the new Stretta Meta-Analysis as well as data on mechanism and GERD outcome measures.
June 13, 2016

New Study: Stretta Treatment of GERD Can Yield Meaningful Cost Savings For Payers

Mederi Therapeutics, Inc., manufacturers of Stretta Therapy for GERD, today announced that a new study, published in Managed Care, suggests the potential for substantial payer cost savings associated with radiofrequency energy (RFE) treatment of GERD patients, as compared to treatment with medical management or fundoplication.
June 13, 2016

New Stretta Data Shows 10-yr Effectiveness in Challenging GERD Patients

Stretta clinical data presented at DDW2016 shows effectiveness in challenging GERD patient populations: Obese patients, laryngopharyngeal reflux (LPR) symptoms, GERD post-nissen. DDW activities also included the launch of the new Stretta RFT3 system and four presentations by international Stretta expert physicians.
May 17, 2016

New Multi-Center Registry To Study Benefits of Stretta for GERD Patients after Sleeve Gastrectomy

Mederi Therapeutics today announced a new multi-center registry that will study the benefit of Stretta Therapy as a treatment option in patients who experience gastroesophageal reflux disease (GERD) after sleeve gastrectomy (SG).
April 15, 2016

Stretta Therapy Acknowledges Esophageal Cancer Awareness Month

Get #GERDSmart! It's time to Get Smart About GERD and help spread the word about the link between chronic reflux and Esophageal Cancer!
January 28, 2016

New Study Confirms Stretta Therapy for GERD to be Safe, Effective and Durable

Stretta Therapy, a non-ablative radiofrequency treatment for GERD, was called "effective, safe and durable following 15 years of worldwide use" and cited as a "viable complement or alternative to medical and surgical treatment" in a newly-published clinical review of endoscopic techniques for gastroesophageal reflux disease (GERD). Authors Wai-Kit Lo, MD, MPH and Hiroshi Mashimo, MD, PhD of Harvard Medical School, examined multiple alternatives to PPI therapy or surgery, including Stretta and other devices such as endoscopic plication and suturing, as well as injectable and implantable bulking agents. Their findings have been published in the Journal of Clinical Gastroenterology.
November 25, 2015

Survey Confirms Holiday Season Marks Higher Incidence Of Reflux Complaints

GERD Awareness Week reinforces the need for patient education and encourages those suffering to determine whether their reflux is diet related or is a chronic condition, as well as to explore treatment options. The results of a survey of U.S. gastroenterologists revealed that physicians see more patients complaining of reflux during the holidays. Appropriately, GERD Awareness Week 2015 kicks off the holiday season, Thanksgiving week – November 22-28.